INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,545,646 | -45.4% | 185,033 | -50.1% | 0.02% | -54.5% |
| Q1 2023 | $13,811,815 | +69561.6% | 370,588 | -34.9% | 0.04% | -45.7% |
| Q4 2022 | $19,827 | -99.8% | 568,952 | +235.1% | 0.08% | +107.7% |
| Q3 2022 | $9,516,000 | +2000.7% | 169,777 | +5963.5% | 0.04% | +3800.0% |
| Q2 2021 | $453,000 | -98.8% | 2,800 | -99.4% | 0.00% | -98.9% |
| Q1 2021 | $38,915,000 | +18431.0% | 484,616 | +4541.9% | 0.09% | – |
| Q3 2020 | $210,000 | -92.5% | 10,440 | -92.2% | 0.00% | -100.0% |
| Q2 2020 | $2,805,000 | – | 133,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |